US Dementia Cases Set to Double by 2050 Amid Care Shortages

The United States faces a sharp rise in dementia diagnoses over the next quarter century, a trend that will test the capacity of a healthcare system already strained by funding reductions and labor shortages. A study published in Jama Neurology projects that new dementia cases globally will more than double, rising from 11.4 million in 2023 to 24.7 million in 2050. In the US, the annual number of adults diagnosed with dementia is expected to climb from 514,000 in 2020 to 1 million by 2060, according to a 2024 Jama study.

Experts attribute this surge to increased life expectancy and demographic shifts. The Hispanic population in the US nearly doubled between 2000 and 2024, a group that is 1.5 times as likely to develop dementia as white people, per the Alzheimer’s Association. Jordan Weiss, an assistant professor at NYU Langone, noted that even with reduced individual risk, the sheer volume of adults entering high-risk age brackets will drive total case numbers upward.

The healthcare infrastructure is currently ill-equipped to handle this growth. The Trump administration has cut Medicaid funding, a program that covers more than half of long-term care costs. The One Big Beautiful Bill Act, passed in 2025, includes nearly $1 trillion in Medicaid cuts over the next decade. Regina Shih, a professor of epidemiology at Emory University, stated that these cuts pose a serious challenge for expanding access to services like home care and respite care for Medicaid-eligible patients.

Staffing gaps compound the financial pressure. A 2024 report from the American Health Care Association found that almost all nursing homes reported difficulty recruiting new staff. Two-thirds of facilities cited a lack of qualified candidates as a primary issue, and about half limited new admissions. The need for nursing assistants is projected to rise by 48% between 2020 and 2035, yet the median wage for these workers was under $19 an hour as of May 2025, according to the Bureau of Labor Statistics.

The shortage of medical specialists is also widening. The number of geriatricians in the US dropped from 10,270 in 2000 to 7,413 in 2022. Geriatrics remains one of the lowest-paid specialties, which experts say discourages new residents. South Carolina has responded by creating a loan forgiveness program for physicians who complete geriatric fellowships and practice in the state for at least five years. A 2025 KFF survey found that almost half of states now offer incentive payments to recruit or retain Medicaid home care workers.

Recent medical advances offer some tools for management but not a cure. The FDA has approved Kisunla and Leqembi, drugs that modestly slow cognitive decline in early Alzheimer’s patients. The agency has also approved blood tests that can aid in diagnosis. Julie Zissimopoulos, principal investigator of the US Cost of Dementia Project, warned that while these tools may improve lives, they will be costly for the healthcare system.

Families are expected to absorb much of the burden. Weiss described the situation as one where families face enormous emotional and financial costs because dementia requires years of increasing supervision. The system is not designed to provide the hands-on care that patients need, leading many families to fill the gap. The median wage for home health aides was $17 an hour in May 2025, a figure that reflects the low compensation for physically and emotionally demanding work.

Experts emphasize that prevention and infrastructure are as important as new drugs. Weiss pointed to cardiovascular health and physical activity as key areas for risk reduction. Shih noted that direct care workers cannot be replaced by artificial intelligence and are not currently adequately reimbursed. The combination of rising case numbers and falling support resources creates a structural challenge for the next 25 years.